NIPH Clinical Trials Search

JRCT ID: jRCT1031230095

Registered date:26/05/2023

Outcomes of trigger finger corticosteroid injection with and without anesthetic

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedTrigger finger
Date of first enrollment26/05/2023
Target sample size60
Countries of recruitment
Study typeInterventional
Intervention(s)We inject within the tendon sheath in two ways. (1) Triamcinolone acetonide 0.1 ml (4 mg) + 1% mepivacaine 0.2 ml ( local anesthetic group) and (2) Triamcinolone acetonide 0.1 ml (4 mg) + 0.2 ml of saline (saline group).


Primary Outcomeprimary efficancy outcime: difference in pain VAS before and 1 month after injection primary safety outcome:Frequency of numbness and adverse events (flexor tendon rupture, tendon sheath rupture, skin atrophy, skin leukoplakia, nerve damage, infection)
Secondary Outcome(1) pain VAS at the time of injection, (2) pain VAS at 10 minutes after injection, and (3) Quinnell classification.

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
Include criteriaTrigger finger, Men and women over 20 years old, No history of injections in the affected finger
Exclude criteriaDiabetic patients, patients with a history of trauma to the affected finger, patients with numbness in the affected finger, patients with symptoms in more than one finger on the affected side at the time of visit, and patients allergic to local anesthetics or steroids.

Related Information


Public contact
Name Hideaki Bo
Address 50, Takashima-cho, Fuji-shi, Shizuoka 417-8567 Japan Shizuoka Japan 417-8567
Telephone +81-90-7800-6646
Affiliation Fuji City General Hospital
Scientific contact
Name Keizo Fukumoto
Address 3-208 Ishihara, Kumagaya-shi, Saitama Saitama Japan 360-0816
Telephone +81-9078006646
Affiliation Saitama Hand &Microsurgery Institute